Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor

Molecular Carcinogenesis

Volumn 20, Issue 4, 1997, Pages 355-365

  Chintala, Shravan K ^a   Mohanam, Sanjeeva ^a   Go, Yoshinori ^a   Venkaiah, Boyapati ^a   Sawaya, Raymond ^a   Gokaslan, Ziya L ^a   Rao, Jasti S ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adhesion; Glioblastoma; Invasion; Plasminogen activators; Spreading; Urokinase type plasminogen activator receptor

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; INTEGRIN; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL INFILTRATION; CELL SPREADING; EXTRACELLULAR MATRIX; GLIOMA CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; MEMBRANE COMPONENT; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR DOWN REGULATION; TUMOR GROWTH;

CELL ADHESION; CELL MOVEMENT; CYTOSKELETON; DNA, ANTISENSE; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; GLIOBLASTOMA; HUMANS; RECEPTORS, CELL SURFACE; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031425359     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199712)20:4<355::AID-MC5>3.0.CO;2-I     Document Type: Article

References (41)

1. Quax PH, van Muijen GNP, Weening-Veroeff EJD, et al. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-I inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115:191-199, 1991.
2. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90:5021-5025, 1993.
3. Pollanen J, Stephens RW, Vaheri A. Directed plasminogen activation at the surface of normal malignant cells. Adv Cancer Res 57:273-328, 1991.
4. Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11:291-311, 1992.
5. Mackay AR, Corbit RH, Hartzler JL, Thorgeirsson UP. Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50:5997-6001, 1990.
6. Hollas W, Blasi F, Boyd D. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 51:3690-3695, 1991.
7. Stahl A, Mueller BM. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54:3066-3071, 1994.
8. Ossawski L. Invasion of connective tissue by human carcinoma cell lines: Requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 52:6754-6760, 1992.
9. Peiffer, J. Neuropathologie. In: Remmele W (ed). Pathologie, Vol. 4. Springer, New York, 1984, p. 253.
10. Geise A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 39: 235-252, 1996.
11. Chintala SK, Rao JS. Invasion of human glioma: Role of extracellular matrix proteins. Frontiers in Bioscience 1: 324-339, 1996.
12. Yamamoto M, Sawaya R, Mohanam S, et al. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res 54:5016-5020, 1994.
13. Mohanam S, Sawaya R, Yamamoto M, Bruner JM, Nicolson GL, Rao JS. Proteolysis and invasion of brain tumor: Role of urokinase-type plasminogen activator receptor. J Neurooncol 22:153-160, 1994.
14. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS. Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen receptor antibody. Cancer Res 53: 4143-4147, 1993.
15. Yamamoto M, Sawaya R, Mohanam S, et al. Expression and localization of urokinase-type plasminogen activator receptor in human glioma. Cancer Res 54: 5016-5020, 1994.
16. Mohanam S, Chintala SK, Go Y, et al. In vitro inhibition of a human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene 14:1351-1359, 1997.
17. Chintala SK, Sawaya R, Gokaslan ZL, Rao JS. Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett 103:201-208, 1996.
18. Zhou L, Zhang SR, Yue BY. Adhesion of human trabecular meshwork cells to extracellular matrix proteins. Roles and distribution of integrin receptors. Invest Ophthalmol Vis Sci 37: 104-113, 1996.
19. Jacot TA, Striker GE, Stetler-Stevenson MA, Striker LJ. Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. Lab Invest 75:791-799, 1996.
20. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266, 1985.
21. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 186:196, 1990.
22. Dumler I, Petri T, Schleuning WD. Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 322:37-40, 1993.
23. Blasi F, Vassalli JD, Dano K. Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors. J Cell Biol 104: 801-804, 1987.
24. Pedersen H, Brunner N, Francis D, et al. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54:4671-4675, 1994.
25. Stahl A, Muller BM. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system, Int J Cancer 71:116-122, 1997.
26. Wei Y, Lukashev M, Simon DI, et al. Regulation of integrin function by the urokinase receptor. Science 273:1551-1555, 1996.
27. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380-32388, 1994.
28. Waltz DA, Chapman HA. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 269:14746-14750, 1994.
29. Pollanen J, Saksela O, Salonen EM, et al. Distinct localization of urokinase-type plasminogen activator and its type 1 inhibitor in cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085-1096, 1987.
30. Conforti G, Dominguez-Jimenez C, Ronne E, Hoyer-Hansen G, Dejana E. Cell-surface plasminogen activation causes a retraction of in vitro cultured human umblical vein endothelial cell monolayer. Blood 83:994-1005, 1994.
31. Nip J, Rabbani SA, Shibata HR, Brodt P. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells. J Clin Invest 95:2096-2103, 1995.
32. Yebra M, Parry GCN, Stromblad S, et al. Requirement of receptor-bound urokinase-type plasminogen activator for integrin αVβ5-directed cell migration. J Biol Chem 271:29393-29399, 1996.
33. Ciambrone GJ, McKeown-Longo PJ. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT1080 cells. J Biol Chem 267:13617-13622, 1992.
34. Pollanen J, Hedman K, Nielsen LS, Dano K, Vaheri A. Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol 106:87-95, 1988.
35. Pollanen J, Saksela O, Salonen E-M, et al. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol 104:1085-1096, 1987.
36. Myohaǹen HT, Stephens RW, Hedman K, et al. Distribution and lateral mobility of the urokinase receptor complex at the cell surface. J Histochem Cytochem 41:1291-1301, 1993.
37. Varner JA, Emerson DA, Juliano RL. lntegrin α5β3 expression negatively regulates cell growth: Reversal by attachment to fibronectin. Mol Biol Cell 6:725-740, 1995.
38. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re-expression of α2β1 integrin abrogates the malignant phenotype of breast carcinoma cell. Proc Natl Acad Sci USA 92:7411-7415, 1995.
39. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extra-cellular matrix: A role in cytoskeletal assembly. J Cell Biol 119: 893-903, 1992.
40. Luna EJ, Hitt AL. Cytoskeleton-plasma membrane interactions. Science 258:955-964, 1992.
41. Pasquale EB, Maher PA, Singer SJ. Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus. Proc Natl Acad Sci USA 83:5507-5511, 1986.